Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ForeignMan
    Member
    • Jun 2010
    • 20

    #1

    Question concering deletions and inversions inferred from PE-sequencing

    Hello everyone,

    I've got two questions concerning the detection of structural variations:

    1.) We sequenced the same cell line twice with the Illumina GA II (paired-end, 100bp read length), but with different insert sizes; ca. 400bp in run1 and 200bp in run2 (ends may overlap here). Kinda strange thing happend here when we detected deletions: In run1 we detected deletions (ca. 1.500) of various sizes (ca. 150bp - 200.000bp), quite a lot of deletions of a few thousand basepairs. In run2 almost 100% of the deletions ranged between only 100bp and 1.000bp. We saw this using Breakdancer and GASV using the same parameters and filtering criteria in both runs. The sequence and fragment coverage is also comparable in both runs. I don't quite understand why there are such big differences and some kind of upper limit in run2. Maybe some of you have experienced something similar.

    2.) Does anyone know an effect during the paired-end sequencing process (Illumina GA II in my case) that can cause artificial inversions? We noticed quite strong deviations in the number of detected inversions across different experiments or samples (we used GASV for variant detection); it ranged from 10 to 20.000 inversions using the same programs and parameters during the analysis. I'd never expect that much inversions and such discrepancies even across different samples. Does someone know if that might be a technical problem in the lab or in the sequencing machine?

    I'd be very glad if someone had some ideas, that help me understand these effects. Thanks in advance.

    Cheers,
    Christoph
    Last edited by ForeignMan; 05-09-2011, 03:56 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...